about
Treatment of Dyslipidemia Using CRISPR/Cas9 Genome Editing.Stem cells and genome editing: approaches to tissue regeneration and regenerative medicine.CRISPR-Cas9 Genome Editing for Treatment of Atherogenic Dyslipidemia.Cardiac Cell Cycle Activation as a Strategy to Improve iPSC-Derived Cardiomyocyte Therapy.The Impact of CRISPR/Cas9 Technology on Cardiac Research: From Disease Modelling to Therapeutic Approaches.Modeling human diseases with induced pluripotent stem cells: from 2D to 3D and beyond.Taking Systems Medicine to Heart.
P2860
Q39333650-25042173-B470-464E-A6A1-BC867DFA8A8DQ47563945-574932F9-A072-4601-A17C-3C3E1CEFC765Q47909228-D88364C1-66A3-4A3D-8753-DB86948D98FCQ48550029-BFF4313B-E7E4-4FC1-8746-3DDA3D20B515Q49432567-45BD6147-8E89-438E-A44D-B0030AB8A8E7Q51417867-A250792B-980E-4F65-B7EA-6CD9D26EEDFFQ52560346-966F32B6-B94D-49D9-8916-582EC454A57F
P2860
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Genome Editing in Cardiovascular Biology.
@en
Genome Editing in Cardiovascular Biology.
@nl
type
label
Genome Editing in Cardiovascular Biology.
@en
Genome Editing in Cardiovascular Biology.
@nl
prefLabel
Genome Editing in Cardiovascular Biology.
@en
Genome Editing in Cardiovascular Biology.
@nl
P2860
P1433
P1476
Genome Editing in Cardiovascular Biology.
@en
P2093
Matthew Porteus
Timon Seeger
P2860
P304
P356
10.1161/CIRCRESAHA.116.310197
P50
P577
2017-03-01T00:00:00Z